Related Experiment Video

Updated: May 9, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Genotoxicity guidelines recommended by International Conference of Harmonization (ICH)

Gireesh H Kamath1, K S Rao

  • 1Syngene International Limited, Bangalore, India.

Methods in Molecular Biology (Clifton, N.J.)
|July 31, 2013
PubMed

Insights

Genotoxicity testing detects genetic damage. The International Council for Harmonisation (ICH) guideline optimizes standard genotoxicity tests for global regulatory consistency and improved risk assessment of carcinogenicity.

Area of Science:

  • Toxicology
  • Genetics
  • Regulatory Science

Background:

  • Genotoxicity tests are crucial for identifying genetic damage induced by various mechanisms.
  • Diverse global regulatory agencies have established distinct mutagenicity testing requirements.
  • This creates challenges as products are developed and marketed internationally.

Purpose of the Study:

  • To optimize the standard battery of genetic toxicology tests.
  • To provide guidance on interpreting genotoxicity test results.
  • To enhance risk characterization for carcinogenicity linked to genetic material changes.

Main Methods:

  • Review and synthesis of existing genotoxicity testing guidelines.
  • Focus on the International Council for Harmonisation (ICH) recommendations.
  • Analysis of how standard test batteries improve risk assessment.

Main Results:

  • The ICH guideline offers a framework for a standardized genotoxicity test battery.
  • This standardization aids in consistent interpretation of results across different regions.
  • The optimized battery improves the characterization of carcinogenic risks originating from genetic damage.

Conclusions:

  • The ICH guideline promotes a harmonized approach to genotoxicity testing.
  • Standardized testing enhances global regulatory efficiency and product safety assessment.
  • This approach does not invalidate other genotoxicity tests but refines risk assessment.

More Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...